Our observations are in agreement with a study in lung cancer concluding that an increase in MMP9 levels after three cycles of chemotherapy was predictive for progression with 5% increase in the odds of progression for an increase of 10 ng of MMP9 [21]. This evidence concerns the gene MMP9 and lung carcinoma.